These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3055361)

  • 1. Buspirone--frontrunner of a new genre of anxiolytics.
    Straughan JL; Conradie EA
    S Afr Med J; 1988 Nov; 74(9):441-4. PubMed ID: 3055361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone, a new approach to the treatment of anxiety.
    Taylor DP
    FASEB J; 1988 Jun; 2(9):2445-52. PubMed ID: 2836252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone: an update on a unique anxiolytic agent.
    Jann MW
    Pharmacotherapy; 1988; 8(2):100-16. PubMed ID: 3041384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol.
    Gebauer DL; Pagnussat N; Piato AL; Schaefer IC; Bonan CD; Lara DR
    Pharmacol Biochem Behav; 2011 Sep; 99(3):480-6. PubMed ID: 21570997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Buspirone: a new non-benzodiazepine anxiolytic drug].
    Honorato J; Catalán M
    Rev Clin Esp; 1990 Apr; 186(6):286-91. PubMed ID: 2203117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone: a worldwide update.
    Napoliello MJ; Domantay AG
    Br J Psychiatry Suppl; 1991 Sep; (12):40-4. PubMed ID: 1840762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.
    Horváth K; Andrási F; Botka P; Hámori T
    Acta Physiol Hung; 1992; 79(2):153-61. PubMed ID: 1363928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Buspirone: a new possibility in the treatment of anxiety].
    Faludi G
    Orv Hetil; 1994 Aug; 135(33):1807-13. PubMed ID: 8072756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V; Martínez Roig M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(4):155-67. PubMed ID: 1356293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
    Ratey J; Sovner R; Parks A; Rogentine K
    J Clin Psychiatry; 1991 Apr; 52(4):159-62. PubMed ID: 2016248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.
    Tollefson GD; Lancaster SP; Montague-Clouse J
    Psychopharmacol Bull; 1991; 27(2):163-70. PubMed ID: 1924664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Buspirone: pharmacological and clinical properties of the first member of a new anxiolytic drug family].
    Bonvalot T; Boulenger JP; Zarifian E
    Rev Med Interne; 1988; 9(1):97-103. PubMed ID: 3285427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buspirone and related compounds on suppressed operant responding in rats.
    Sanger DJ
    J Pharmacol Exp Ther; 1990 Aug; 254(2):420-6. PubMed ID: 1974634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristics of the pharmacological action of buspirone].
    Dzhagatspanian IA; Asrian AB
    Eksp Klin Farmakol; 1994; 57(1):5-8. PubMed ID: 8142866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.